These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 35880177)

  • 1. γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.
    Chan KF; Duarte JDG; Ostrouska S; Behren A
    Front Immunol; 2022; 13():894315. PubMed ID: 35880177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
    Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
    Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune recognition of phosphoantigen-butyrophilin molecular complexes by γδ T cells.
    Uldrich AP; Rigau M; Godfrey DI
    Immunol Rev; 2020 Nov; 298(1):74-83. PubMed ID: 33017054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2
    Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S
    J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.
    Payne KK; Mine JA; Biswas S; Chaurio RA; Perales-Puchalt A; Anadon CM; Costich TL; Harro CM; Walrath J; Ming Q; Tcyganov E; Buras AL; Rigolizzo KE; Mandal G; Lajoie J; Ophir M; Tchou J; Marchion D; Luca VC; Bobrowicz P; McLaughlin B; Eskiocak U; Schmidt M; Cubillos-Ruiz JR; Rodriguez PC; Gabrilovich DI; Conejo-Garcia JR
    Science; 2020 Aug; 369(6506):942-949. PubMed ID: 32820120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More.
    Herrmann T; Karunakaran MM
    Front Immunol; 2022; 13():876493. PubMed ID: 35371078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
    Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP
    Science; 2020 Feb; 367(6478):. PubMed ID: 31919129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γδ T Cells in Tumor Microenvironment.
    Imbert C; Olive D
    Adv Exp Med Biol; 2020; 1273():91-104. PubMed ID: 33119877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
    Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
    Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
    Miyashita M; Shimizu T; Ashihara E; Ukimura O
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?
    Gougeon ML; Malkovsky M; Casetti R; Agrati C; Poccia F
    Vaccine; 2002 May; 20(15):1938-41. PubMed ID: 11983250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses.
    Brandes M; Willimann K; Bioley G; Lévy N; Eberl M; Luo M; Tampé R; Lévy F; Romero P; Moser B
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2307-12. PubMed ID: 19171897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules.
    Liu Y; Lui KS; Ye Z; Fung TY; Chen L; Sit PY; Leung CY; Mak NK; Wong KL; Lung HL; Tanaka Y; Cheung AKL
    Theranostics; 2023; 13(2):458-471. PubMed ID: 36632221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression level of BTN3A1 on the surface of CD14
    Tomogane M; Omura M; Sano Y; Shimizu D; Toda Y; Hosogi S; Kimura S; Ashihara E
    Biochem Biophys Res Commun; 2022 Jan; 588():47-54. PubMed ID: 34952469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.
    Rhodes DA; Chen HC; Price AJ; Keeble AH; Davey MS; James LC; Eberl M; Trowsdale J
    J Immunol; 2015 Mar; 194(5):2390-8. PubMed ID: 25637025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.
    Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M
    Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glance over the fence: Using phylogeny and species comparison for a better understanding of antigen recognition by human γδ T-cells.
    Herrmann T; Karunakaran MM; Fichtner AS
    Immunol Rev; 2020 Nov; 298(1):218-236. PubMed ID: 32981055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
    Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations.
    Nerdal PT; Peters C; Oberg HH; Zlatev H; Lettau M; Quabius ES; Sousa S; Gonnermann D; Auriola S; Olive D; Määttä J; Janssen O; Kabelitz D
    J Immunol; 2016 Oct; 197(8):3059-3068. PubMed ID: 27619996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
    Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
    Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.